Tonix Pharmaceuticals Holding (TNXP) Long-Term Investments (2026)
Tonix Pharmaceuticals Holding (TNXP) posted Long-Term Investments of $1.9 million for Q2 2026, up 18.75% on a QoQ basis from $1.6 million in Q1 2026.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Long-Term Investments (2026) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Long-Term Investments for 1 years, with the latest figure at $1.9 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | - |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 1.56 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 3.73 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | - |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 345.03 Mn |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn | 1.87 Mn |